Functional experiments confirmed that knocking down p21 expression in a DMM surgery-induced mouse OA model exacerbated articular cartilage degradation and was accompanied by a significant decrease in GPX4 protein levels in vivo , demonstrating that p21 plays an important anti-ferroptotic role in OA progression by modulating GPX4 stability (Zheng et al., 2024)
Patients with severe renal impairment have not been adequately studied
Retatrutide is an investigational triple agonist medicine that simultaneously activates glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Patients should avoid areas with active skin conditions, scars, moles, or recent sunburn
A prospective patient completes an online evaluation, a licensed clinician reviews it, and, when appropriate, a prescription is issued for either an FDA-approved brand GLP-1 or a compounded semaglutide or tirzepatide prepared by a licensed compounding pharmacy
